{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:16:04Z","timestamp":1789229764941,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To study the angiogenic capacity of antimicrobial peptide LL37 (cathelicidin antimicrobial peptide), explore its molecular mechanisms, and provide new ideas for treating lower limb ischemic diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>LL37 was applied exogenously to human umbilical vein endothelial cells (HUVECs), and its effects on cell proliferation, migration, and angiogenesis were assessed using Cell Counting Kit-8 (CCK-8), plate cloning, scratch, and angiogenesis assays. A mouse lower limb ischemia model was established, with LL37 injected intramuscularly on days 0, 4, and 8. Blood flow recovery was evaluated by laser Doppler flowmetry. Immunofluorescence staining detected cluster of differentiation 31 (CD31) and cluster of differentiation 34 (CD34) expression, while Hematoxylin and Eosin (H&amp;amp;E) staining assessed muscle cell morphology. Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting analyzed gene and protein expression changes in HUVECs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LL37 enhanced the proliferative, migratory, and pro-angiogenic abilities of HUVECs. It significantly improved blood flow recovery in ischemic limbs, with higher CD31\/CD34 expression and more intact muscle morphology. qRT-PCR analysis demonstrated elevated expression of angiogenesis-related genes in LL37-treated HUVECs. Western blotting revealed increased vascular endothelial growth factor A (VEGFA) expression and enhanced phosphorylation levels of the phosphatidylinositol 3-kinase (PI3K)\/protein kinase B (AKT)\/mammalian target of rapamycin (mTOR) pathway in LL37-treated cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LL37 promotes angiogenesis via the VEGFA-PI3K\/AKT\/mTOR pathway, showing potential for treating lower limb ischemia by improving perfusion.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1587351","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:10:43Z","timestamp":1745381443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["LL37 promotes angiogenesis: a potential therapeutic strategy for lower limb ischemic diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Yingying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3390\/cimb45030150","article-title":"Effect of atorvastatin on angiogenesis-related genes VEGF-A, HGF and IGF-1 and the modulation of PI3K\/AKT\/mTOR transcripts in bone-marrow-derived mesenchymal stem cells","volume":"45","author":"Adami\u010dkov\u00e1","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5114\/ceji.2015.51359","article-title":"Cathelicidin impact on inflammatory cells","volume":"40","author":"Agier","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/ewjm.173.1.60","article-title":"Chronic lower limb ischemia","volume":"173","author":"Beard","year":"2000","journal-title":"West J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijpharm.2017.04.082","article-title":"Cubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stability","volume":"526","author":"Boge","year":"2017","journal-title":"Int. J. Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.yasu.2024.04.008","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"58","author":"Cheng","year":"2024","journal-title":"Adv. Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/0008-5472.CAN-21-0003","article-title":"Phosphoinositide-binding protein TIPE1 promotes alternative activation of macrophages and tumor progression via PIP3\/akt\/tgf\u03b2 Axis","volume":"82","author":"Cheng","year":"2022","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2174\/1381612824666180327113418","article-title":"Tissue-specific regulation of innate immune responses by human cathelicidin LL-37","volume":"24","author":"Chieosilapatham","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"B8","first-page":"671","article-title":"Involvement of endothelial PECAM-1\/CD31 in angiogenesis","volume":"151","author":"DeLisser","year":"1997","journal-title":"Am. J. Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13287-024-03957-0","article-title":"Mesenchymal stromal cell therapy (REGENACIP(\u00ae)), a promising treatment option in chronic limb threatening ischemia - a narrative review","volume":"15","author":"Desai","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9010","DOI":"10.3390\/ijms23169010","article-title":"Comparison of the behavior of perivascular cells (pericytes and CD34+ stromal cell\/telocytes) in sprouting and intussusceptive angiogenesis","volume":"23","author":"D\u00edaz-Flores","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/CIRCRESAHA.120.316851","article-title":"Basic and therapeutic aspects of angiogenesis updated","volume":"127","author":"Eelen","year":"2020","journal-title":"Circ. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1039\/c5mb00101c","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol. Biosyst."},{"key":"B13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1152\/ajplegacy.1962.203.3.470","article-title":"Blood flow from and oxygen uptake by muscle, during and after partial venous occlusion","volume":"203","author":"Fales","year":"1962","journal-title":"Am. J. Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJMcp1709326","article-title":"Chronic limb-threatening ischemia","volume":"379","author":"Farber","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14670\/HH-18-038","article-title":"Double immunofluorescence labeling for CD31 and CD105 as a marker for polyether polyurethane-induced angiogenesis in mice","volume":"34","author":"Figueiredo","year":"2019","journal-title":"Histol. Histopathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.2174\/138920112802273155","article-title":"Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases","volume":"13","author":"Frasca","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1089\/sur.2018.194","article-title":"Antimicrobial peptides","volume":"19","author":"Fry","year":"2018","journal-title":"Surg. Infect. (Larchmt)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/genes11091045","article-title":"Regulation of mTORC2 signaling","volume":"11","author":"Fu","year":"2020","journal-title":"Genes (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"104928","DOI":"10.1016\/j.micinf.2021.104928","article-title":"Bactericidal effects and stability of LL-37 and CAMA in the presence of human lung epithelial cells","volume":"24","author":"Geitani","year":"2022","journal-title":"Microbes Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 promotes tumorigenesis via lipid synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/PAI.0000000000000693","article-title":"CD31 immunohistochemical expression in tumors","volume":"27","author":"Handra-Luca","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.dld.2023.05.010","article-title":"Tumor suppressor CLCA1 inhibits angiogenesis via TGFB1\/SMAD\/VEGF cascade and sensitizes hepatocellular carcinoma cells to Sorafenib","volume":"56","author":"He","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jaad.2004.08.026","article-title":"Antimicrobial peptides","volume":"52","author":"Izadpanah","year":"2005","journal-title":"J. Am. Acad. Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2174\/1871527321666220329144538","article-title":"Danshensu enhances cerebral angiogenesis in mice by regulating the PI3K\/Akt\/Mtor\/VEGF signaling Axis","volume":"22","author":"Jia","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/iej.12365","article-title":"LL37 induces VEGF expression in dental pulp cells through ERK signalling","volume":"48","author":"Khung","year":"2015","journal-title":"Int. Endod. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.3390\/ani13223452","article-title":"Refinement of animal experiments: replacing traumatic methods of laboratory animal marking with non-invasive alternatives","volume":"13","author":"Klabukov","year":"2023","journal-title":"Anim. (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2169\/internalmedicine.40.565","article-title":"Angiogenesis factors","volume":"40","author":"Kuwano","year":"2001","journal-title":"Intern Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13046-024-03003-0","article-title":"Gli1-mediated tumor cell-derived bFGF promotes tumor angiogenesis and pericyte coverage in non-small cell lung cancer","volume":"43","author":"Lei","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tcm.2019.04.002","article-title":"Lower extremity critical limb ischemia: a review of clinical features and management","volume":"30","author":"Levin","year":"2020","journal-title":"Trends Cardiovasc Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1024\/0301-1526\/a000527","article-title":"Treatment of acute lower limb ischaemia","volume":"45","author":"Lukasiewicz","year":"2016","journal-title":"Vasa"},{"key":"B34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fimmu.2019.00283","article-title":"LL37 inhibits Aspergillus fumigatus infection via directly binding to the fungus and preventing excessive inflammation","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000516498","article-title":"Possible mechanism of human recombinant leptin-induced VEGF A synthesis via PI3K\/Akt\/mTOR\/S6 kinase signaling pathway while inducing angiogenesis: an analysis using chicken chorioallantoic membrane model","volume":"58","author":"Manjunathan","year":"2021","journal-title":"J. Vasc. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.21873\/cdp.10200","article-title":"Impact of CD34-dependent micro vessel density on periapical odontogenic cysts","volume":"3","author":"Mathiou","year":"2023","journal-title":"Cancer Diagn Progn."},{"key":"B37","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.3390\/ijms21175973","article-title":"Therapeutic potential of cathelicidin peptide LL-37, an antimicrobial agent, in a murine sepsis model","volume":"21","author":"Nagaoka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.tcb.2022.04.012","article-title":"Non-canonical mTORC1 signaling at the lysosome","volume":"32","author":"Napolitano","year":"2022","journal-title":"Trends Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"119634","DOI":"10.1016\/j.carbpol.2022.119634","article-title":"Delivery LL37 by chitosan nanoparticles for enhanced antibacterial and antibiofilm efficacy","volume":"291","author":"Rashki","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"B41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbrc.2019.03.142","article-title":"Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer","volume":"512","author":"Ren","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-4632.2008.03340.x","article-title":"LL-37 regulates the overexpression of vascular endothelial growth factor (VEGF) and c-IAP-2 in human keratinocytes","volume":"47","author":"Rodr\u00edguez-Mart\u00ednez","year":"2008","journal-title":"Int. J. Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.4049\/jimmunol.171.12.6690","article-title":"The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor","volume":"171","author":"Tjabringa","year":"2003","journal-title":"J. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.addr.2018.09.010","article-title":"Therapeutic strategies for enhancing angiogenesis in wound healing","volume":"146","author":"Veith","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/1078-0432.CCR-17-1778","article-title":"CD31 expression determines redox status and chemoresistance in human angiosarcomas","volume":"24","author":"Venkataramani","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"106920","DOI":"10.1016\/j.vph.2021.106920","article-title":"Tetrandrine promotes angiogenesis via transcriptional regulation of VEGF-A","volume":"141","author":"Wang","year":"2021","journal-title":"Vasc. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1253\/circj.cj-11-0103","article-title":"Advances in endovascular treatment of critical limb ischemia","volume":"75","author":"Yan","year":"2011","journal-title":"Circ. J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1024\/0301-1526.38.1.3","article-title":"New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia","volume":"38","author":"Zeller","year":"2009","journal-title":"Vasa"},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/19336918.2023.2168231","article-title":"Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model","volume":"17","author":"Zhang","year":"","journal-title":"Cell Adh Migr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1151926","DOI":"10.3389\/fimmu.2023.1151926","article-title":"Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation","volume":"14","author":"Zhang","year":"","journal-title":"Front. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/iep.12485","article-title":"Mechanism of the HIF-1\u03b1\/VEGF\/VEGFR-2 pathway in the proliferation and apoptosis of human haemangioma endothelial cells","volume":"104","author":"Zhang","year":"","journal-title":"Int. J. Exp. Pathol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1587351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:10:45Z","timestamp":1745381445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1587351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":53,"alternative-id":["10.3389\/fphar.2025.1587351"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1587351","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"article-number":"1587351"}}